Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 26,000 shares at $32.00 ($832K) on 2016-04-07, disclosed to the SEC on 2016-04-08.
Open-market sale of $832k XLRN by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.00 | 2,080 | $67K | 8.0% |
| 2 | $32.00 | 23,920 | $765K | 92.0% |
| Total | $32.00 avg | 26,000 | $832K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |